Capstone Holding Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Capstone Holding Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $44.88M | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | $48.35M | Apr 17, 2026 |
| FY2018 | Dec 31, 2018 | ($2.00M) | Mar 22, 2019 |
| FY2018 | Jun 30, 2018 | $2.00M | Mar 22, 2019 |
| FY2018 | Dec 31, 2017 | $0 | Mar 22, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $45.81M | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | $48.64M | Apr 17, 2026 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.79M | Apr 16, 2026 |
| FY2024 | Dec 31, 2024 | $9.57M | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | $9.61M | Apr 17, 2026 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($21.23M) | Apr 16, 2026 |
| FY2024 | Dec 31, 2024 | ($2.56M) | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | ($3.82M) | Apr 17, 2026 |
| FY2018 | Dec 31, 2018 | $380.0K | Mar 22, 2019 |
| FY2018 | Dec 31, 2017 | $1.76M | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | ($663.0K) | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | ($2.77M) | Oct 30, 2017 |
| FY2015 | Dec 31, 2014 | ($4.17M) | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | ($3.92M) | Mar 16, 2015 |
| FY2013 | Dec 31, 2012 | ($3.58M) | Mar 27, 2014 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($10.99M) | Apr 16, 2026 |
| FY2024 | Dec 31, 2024 | ($638.0K) | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | ($1.26M) | Apr 17, 2026 |
| FY2018 | Dec 31, 2018 | $181.0K | Mar 22, 2019 |
| FY2018 | Dec 31, 2017 | $1.68M | Mar 22, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $52.0K | Mar 22, 2019 |
| FY2013 | Dec 31, 2013 | $1.0K | Mar 27, 2014 |
| FY2013 | Dec 31, 2012 | $9.0K | Mar 27, 2014 |
| FY2012 | Dec 31, 2011 | $21.0K | Mar 14, 2013 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.37M | Apr 16, 2026 |
| FY2024 | Dec 31, 2024 | $10.21M | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | $10.87M | Apr 17, 2026 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($4.41M) | Apr 16, 2026 |
| FY2024 | Dec 31, 2024 | $3.82M | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | $1.65M | Apr 17, 2026 |
| FY2018 | Dec 31, 2018 | $66.0K | Mar 22, 2019 |
| FY2018 | Dec 31, 2017 | ($1.56M) | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | ($1.26M) | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | ($2.15M) | Oct 30, 2017 |
| FY2013 | Dec 31, 2013 | ($3.95M) | Mar 27, 2014 |
| FY2013 | Dec 31, 2012 | ($3.37M) | Mar 27, 2014 |
| FY2012 | Dec 31, 2011 | ($10.59M) | Mar 14, 2013 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $122.0K | Apr 16, 2026 |
| FY2024 | Dec 31, 2024 | $120.0K | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | $208.0K | Apr 17, 2026 |
| FY2013 | Dec 31, 2013 | $0 | Mar 27, 2014 |
| FY2013 | Dec 31, 2012 | $0 | Mar 27, 2014 |
| FY2012 | Dec 31, 2011 | $19.0K | Mar 14, 2013 |
| FY2011 | Dec 31, 2010 | $60.0K | Mar 21, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.38M | Apr 16, 2026 |
| FY2024 | Dec 31, 2024 | $47.22M | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | $52.70M | Apr 17, 2026 |
| FY2018 | Dec 31, 2018 | $1.48M | Mar 22, 2019 |
| FY2018 | Dec 31, 2017 | $1.57M | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | $1.18M | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $1.77M | Oct 30, 2017 |
| FY2015 | Dec 31, 2014 | $3.39M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $7.32M | Mar 16, 2015 |
| FY2013 | Dec 31, 2012 | $11.59M | Mar 27, 2014 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.93M | Apr 16, 2026 |
| FY2024 | Dec 31, 2024 | $20.66M | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | $23.58M | Apr 17, 2026 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.45M | Apr 16, 2026 |
| FY2024 | Dec 31, 2024 | ($3.06M) | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | $2.44M | Apr 17, 2026 |
| FY2024 | Dec 31, 2022 | $8.17M | Apr 17, 2026 |
| FY2018 | Dec 31, 2018 | ($1.24M) | Mar 22, 2019 |
| FY2018 | Dec 31, 2017 | ($879.0K) | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | ($122.0K) | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $506.0K | Oct 30, 2017 |
| FY2015 | Dec 31, 2014 | $3.10M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $7.22M | Mar 16, 2015 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.46M | Apr 16, 2026 |
| FY2024 | Dec 31, 2024 | $23.29M | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | $23.29M | Apr 17, 2026 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($218.04M) | Apr 16, 2026 |
| FY2024 | Dec 31, 2024 | ($196.10M) | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | ($190.61M) | Apr 17, 2026 |
| FY2018 | Dec 31, 2018 | ($191.75M) | Mar 22, 2019 |
| FY2018 | Dec 31, 2017 | ($191.37M) | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | ($189.62M) | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | ($188.96M) | Oct 30, 2017 |
| FY2015 | Dec 31, 2014 | ($186.19M) | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | ($182.02M) | Mar 16, 2015 |
| FY2013 | Dec 31, 2012 | ($178.10M) | Mar 27, 2014 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $727.0K | Apr 16, 2026 |
| FY2024 | Dec 31, 2024 | $11.0K | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | $52.0K | Apr 17, 2026 |
| FY2018 | Dec 31, 2018 | $1.34M | Mar 22, 2019 |
| FY2018 | Dec 31, 2017 | $1.28M | Mar 22, 2019 |
| FY2018 | Dec 31, 2016 | $698.0K | Mar 22, 2019 |
| FY2017 | Dec 31, 2015 | $1.01M | Feb 28, 2018 |
| FY2016 | Dec 31, 2014 | $2.16M | Oct 30, 2017 |
| FY2015 | Dec 31, 2013 | $6.26M | Mar 30, 2016 |
| FY2014 | Dec 31, 2012 | $10.21M | Mar 16, 2015 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.05M | Apr 16, 2026 |
| FY2024 | Dec 31, 2024 | $8.44M | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | $9.00M | Apr 17, 2026 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (4) | Apr 16, 2026 |
| FY2024 | Dec 31, 2024 | (34) | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | (36) | Apr 17, 2026 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | (34) | Apr 17, 2026 |
| FY2024 | Dec 31, 2023 | (36) | Apr 17, 2026 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8.77M | Apr 16, 2026 |
| FY2018 | Dec 31, 2018 | 54.39M | Mar 22, 2019 |
| FY2018 | Dec 31, 2017 | 54.39M | Mar 22, 2019 |
| FY2017 | Dec 31, 2016 | 40.89M | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | 40.89M | Oct 30, 2017 |
| FY2015 | Dec 31, 2014 | 40.89M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | 40.89M | Mar 16, 2015 |
| FY2013 | Dec 31, 2012 | 40.89M | Mar 27, 2014 |
| FY2012 | Dec 31, 2011 | 40.78M | Mar 14, 2013 |
| FY2011 | Dec 31, 2010 | 40.78M | Mar 21, 2012 |